Log in
Enquire now
‌

US Patent 10308648 Inhibitors of cyclin-dependent kinase 7 (CDK7)

Patent 10308648 was granted and assigned to Syros Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Syros Pharmaceuticals
Syros Pharmaceuticals
0
Date Filed
October 15, 2015
0
Date of Patent
June 4, 2019
0
Patent Applicant
Syros Pharmaceuticals
Syros Pharmaceuticals
0
Patent Application Number
15519484
0
Patent Citations Received
‌
US Patent 10738067 Inhibitors of cyclin-dependent kinase 7 (CDK7)
‌
US Patent 10865206 Inhibitors of cyclin-dependent kinase 7 (CDK7)
Patent Inventor Names
Tom Miller
0
Serge Leger
0
Stephane Ciblat
0
Stephanie Roy
0
Amy Ripka
0
Anzhelika Kabro
0
Arshad M. Siddiqui
0
Dana K. Winter
0
Dansu Li
0
Darby Schmidt
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10308648
0
Patent Primary Examiner
‌
Alexander R Pagano
0

Find more entities like US Patent 10308648 Inhibitors of cyclin-dependent kinase 7 (CDK7)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.